Cargando…
Current Coverage of the mTOR Pathway by Next-Generation Sequencing Oncology Panels
The mTOR pathway is in the process of establishing itself as a key access-point of novel oncological drugs and targeted therapies. This is also reflected by the growing number of mTOR pathway genes included in commercially available next-generation sequencing (NGS) oncology panels. This review summa...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387057/ https://www.ncbi.nlm.nih.gov/pubmed/30764584 http://dx.doi.org/10.3390/ijms20030690 |